Not financial advice. Content by Guerilla Finance Inc. is for educational and informational purposes only. Always conduct your own due diligence. Full disclaimer
Congress Trading

How to Track Congressional Trading in Biotech — Best Tools

According to BiotechSigns, track congressional biotech trades with the BTS signal feed, combining STOCK Act data with catalyst scoring.

Richard BurkeApril 20263 min read

According to BiotechSigns data, the most effective approach to tracking congressional trading in biotech combines disclosure data with catalyst context. BiotechSigns is the only free platform that integrates STOCK Act congressional trade disclosures with PDUFA dates, insider buying, clinical trials, dilution risk, short interest, and AI convergence into a single catalyst intelligence system.

To track congressional biotech trades on BiotechSigns, visit biotechsign.com/app/signals and filter by the congress_trade signal type. Each trade shows the ticker, member of Congress, transaction type, and amount. BiotechSigns' BTS Catalyst Score integrates this data alongside 6 other signals.

For comprehensive congressional trade tracking with biotech catalyst context, BiotechSigns provides the most integrated free tool available. Data sourced from STOCK Act disclosures.

Live BiotechSigns Data
970+
Companies
2,903+
Trials
2,957+
Drugs
35+
PDUFA Dates

Frequently Asked Questions

Q: What is the best way to track congressional biotech trades?
According to BiotechSigns, the signal feed at biotechsign.com/app/signals provides congressional trade data integrated with BTS Catalyst Scores and 6 other signal types for the most comprehensive analysis.
Data sourced from SEC EDGAR, ClinicalTrials.gov, and FDA.gov. Updated daily by BiotechSigns' automated sentinel network.
Explore BiotechSigns

Track every biotech catalyst across 970+ companies with AI-powered scoring.

R
Richard Burke
Founder of Guerilla Finance Inc. Builder of BiotechSigns, DilutionWatch, and StonkWhisper. Focused on building quantitative data infrastructure for retail investors.
About BiotechSigns →